Plasma EMMPRIN levels in acute myocardial infarction and stable coronary artery disease

---

Akkus M. N., Orman A., Seyis S., BARAN Ç., Gorur A., Bilen M. N.

CLINICAL AND INVESTIGATIVE MEDICINE, cilt.39, sa.3, 2016 (SCI-Expanded, Scopus)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 39 Sayı: 3
• Basım Tarihi: 2016
• Doi Numarası: 10.25011/cim.v39i3.26796
• Dergi Adı: CLINICAL AND INVESTIGATIVE MEDICINE
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
• Ankara Üniversitesi Adresli: Evet

Özet

Purpose: The purpose of this study was to determine whether the plasma levels of soluble extracellular matrix metalloproteinase inducer (EMMPRIN) differed among the patients with ST-elevation myocardial infarction (STEMI), non-STEMI (NSTEMI) and stable coronary artery disease (CAD) and the healthy controls, and to identify the factors associated with the differences in plasma levels of this this protein among patients in these groups.